(Q48672617)

14 February 2018

title

Melanocyte-stimulating hormone and parkinsonism. (English)

1 reference

14 February 2018

1 reference

S Shuster

1

1 reference

14 February 2018

A J Thody

2

1 reference

14 February 2018

S K Goolamali

3

1 reference

14 February 2018

J L Burton

4

1 reference

14 February 2018

N Plummer

5

1 reference

14 February 2018

D Bates

6

1 reference

14 February 2018

language of work or name

English

0 references

publication date

1 March 1973

1 reference

14 February 2018

published in

The Lancet

1 reference

14 February 2018

volume

1

1 reference

14 February 2018

issue

7801

1 reference

14 February 2018

page(s)

463-464

1 reference

14 February 2018

Effect of L-dopa on seborrhoea of parkinsonism.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2991885-0

7 January 2021

A new approach to the reduction of sebum secretion.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2991885-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2991885-0

1 reference

7 January 2021

Control of Sebum Secretion by the Posterior Pituitary

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2991885-0

7 January 2021

Sebotrophic activity of beta-lipotrophin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2991885-0

7 January 2021

Luteinizing Hormone-Releasing Activity in Hypophysial Stalk Blood and Elevation by Dopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2991885-0

7 January 2021

Mono- and indolamines and control of LH secretion.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2991885-0

7 January 2021

Effect of Anterior Pituitary Perfusion and Intraventricular Injection of Catecholamines on FSH Release1

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2991885-0

7 January 2021

Effect of Anterior Pituitary Perfusion and Intraventricular Injection of Catecholamines on Prolactin Release1

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2991885-0

7 January 2021

Effect of L-dopa administration on growth hormone secretion in normal subjects and Parkinsonian patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2991885-0

7 January 2021

Aromatic Amino Acids and Modification of Parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2991885-0

7 January 2021

DOPA potentiation by a hypothalamic factor, MSH release-inhibiting hormone (MIF).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2991885-0

7 January 2021

Spectroscopic studies of substantia nigra pigment in human subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2991885-0

7 January 2021

Infrared spectrometry of locus coeruleus and substantia nigra pigments in human brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2991885-0

7 January 2021

Dopa and dopamine in the pigment of substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2991885-0

7 January 2021

10.1016/S0140-6736(73)91885-0

Identifiers

DOI

1 reference

14 February 2018

PubMed ID

4120371

1 reference

14 February 2018